RXRX
RECURSION PHARMACEUTICALS, INC.
+0.27 (+8.62%)3.47USD13.4M成交股數1.9B市值–本益比(近四季)33.8股價營收比-60.1%營收年增(近四季)2026-11-04下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 4 · 435K · 2 |
| 其中 10b5-1 計畫賣出 | 4 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 1.7M |
| 近 180 天 淨額 | −1.7M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | 09-17 | Taylor Ben R | Chief Financial Officer | F 繳稅扣股 | 5.4K | 3.41 | 18K | 1.1M | SEC |
| 2026-09-08 | 09-10 | Khan Najat | CEO and President | S 公開市場賣出(10b5-1) | 22.4K | 3.52 | 79K | 2.1M | SEC |
| 2026-09-01 | 09-02 | Borgeson Blake | Director | S 公開市場賣出(10b5-1) | 30.0K | 3.34 | 100K | 6.2M | SEC |
| 2026-08-17 | 08-18 | Hallett David | Chief Scientific Officer | F 繳稅扣股 | 26.7K | 3.16 | 84K | 1.0M | SEC |
| 2026-08-17 | 08-18 | Khan Najat | CEO and President | F 繳稅扣股 | 80.5K | 3.16 | 254K | 2.1M | SEC |
| 2026-08-17 | 08-18 | Taylor Ben R | Chief Financial Officer | F 繳稅扣股 | 25.0K | 3.16 | 79K | 1.1M | SEC |
| 2026-08-04 | 08-06 | Borgeson Blake | Director | S 公開市場賣出(10b5-1) | 30.0K | 3.25 | 98K | 6.2M | SEC |
| 2026-07-07 | 07-09 | Borgeson Blake | Director | S 公開市場賣出(10b5-1) | 40.0K | 3.96 | 159K | 6.2M | SEC |
| 2026-07-01 | 07-02 | Dar Zavain | Director | A 獲配股票 | 5.1K | – | – | 241K | SEC |
| 2026-07-01 | 07-02 | Li Dean Y | Director | A 獲配股票 | 3.7K | – | – | 1.5M | SEC |
| 2026-06-18 | 06-22 | Bumpus Namandje | Director | S 公開市場賣出(10b5-1) | 4.0K | 3.18 | 13K | 128K | SEC |
| 2026-06-17 | 06-22 | Sun Elaine D | Director | A 獲配股票 | 88.4K | – | – | 136K | SEC |
| 2026-06-17 | 06-22 | Li Dean Y | Director | A 獲配股票 | 88.4K | – | – | 1.5M | SEC |
| 2026-06-17 | 06-22 | Dar Zavain | Director | A 獲配股票 | 88.4K | – | – | 236K | SEC |
| 2026-06-17 | 06-22 | Bumpus Namandje | Director | A 獲配股票 | 88.4K | – | – | 132K | SEC |
| 2026-06-17 | 06-22 | Borgeson Blake | Director | A 獲配股票 | 88.4K | – | – | 6.3M | SEC |
| 2026-06-17 | 06-22 | HERSHBERG ROBERT | Director | A 獲配股票 | 88.4K | – | – | 162K | SEC |
| 2026-06-17 | 06-22 | Michor Franziska | Director | A 獲配股票 | 88.4K | – | – | 215K | SEC |
| 2026-06-15 | 06-17 | Taylor Ben R | Chief Financial Officer | F 繳稅扣股 | 5.4K | 3.15 | 17K | 1.1M | SEC |
| 2026-06-05 | 06-05 | Khan Najat | CEO and President | S 公開市場賣出(10b5-1) | 23.6K | 3.58 | 84K | 2.2M | SEC |
| 2026-06-05 | 06-05 | Gibson Christopher | Director | S 公開市場賣出(10b5-1) | 40.0K | 3.62 | 145K | 884K | SEC |
| 2026-06-05 | 06-05 | Gibson Christopher | Director | C 轉換 | 40.0K | – | – | 924K | SEC |
| 2026-06-03 | 06-04 | Bumpus Namandje | Director | S 公開市場賣出(10b5-1) | 4.4K | 3.54 | 16K | 43.2K | SEC |
| 2026-06-02 | 06-04 | Borgeson Blake | Director | S 公開市場賣出(10b5-1) | 30.0K | 3.68 | 110K | 6.2M | SEC |
| 2026-05-22 | 05-27 | Gibson Christopher | Director | C 轉換 | 40.0K | – | – | 924K | SEC |
| 2026-05-22 | 05-27 | Gibson Christopher | Director | S 公開市場賣出(10b5-1) | 40.0K | 3.08 | 123K | 884K | SEC |
| 2026-05-15 | 05-19 | Hallett David | Chief Scientific Officer | F 繳稅扣股 | 26.7K | 3.04 | 81K | 1.1M | SEC |
| 2026-05-15 | 05-19 | Gibson Christopher | Director | F 繳稅扣股 | 22.8K | 3.04 | 69K | 884K | SEC |
| 2026-05-15 | 05-19 | Taylor Ben R | Chief Financial Officer | F 繳稅扣股 | 25.0K | 3.04 | 76K | 1.1M | SEC |
| 2026-05-15 | 05-19 | Khan Najat | CEO and President | F 繳稅扣股 | 62.7K | 3.04 | 191K | 2.2M | SEC |
| 2026-05-07 | 05-08 | Gibson Christopher | Director | C 轉換 | 60.0K | – | – | 967K | SEC |
| 2026-05-07 | 05-08 | Gibson Christopher | Director | G 贈與 | 20.0K | – | – | 907K | SEC |
| 2026-05-07 | 05-08 | Gibson Christopher | Director | S 公開市場賣出(10b5-1) | 40.0K | 3.37 | 135K | 927K | SEC |
| 2026-05-05 | 05-07 | Borgeson Blake | Director | S 公開市場賣出(10b5-1) | 30.0K | 3.52 | 106K | 6.2M | SEC |
| 2026-04-22 | 04-24 | Gibson Christopher | Director | S 公開市場賣出(10b5-1) | 40.0K | 3.61 | 144K | 907K | SEC |
| 2026-04-22 | 04-24 | Gibson Christopher | Director | C 轉換 | 40.0K | – | – | 947K | SEC |
| 2026-04-07 | 04-08 | Borgeson Blake | Director | S 公開市場賣出(10b5-1) | 30.0K | 3.10 | 93K | 6.2M | SEC |
| 2026-04-07 | 04-08 | Gibson Christopher | Director | S 公開市場賣出(10b5-1) | 40.0K | 3.10 | 124K | 907K | SEC |
| 2026-04-07 | 04-08 | Gibson Christopher | Director | C 轉換 | 40.0K | – | – | 947K | SEC |
| 2026-04-06 | 04-08 | Taylor Ben R | Chief Financial Officer | F 繳稅扣股 | 48.0K | 3.11 | 149K | 1.1M | SEC |
| 2026-04-01 | 04-02 | Li Dean Y | Director | A 獲配股票 | 3.3K | – | – | 1.2M | SEC |
| 2026-04-01 | 04-02 | Dar Zavain | Director | A 獲配股票 | 4.9K | – | – | 147K | SEC |
| 2026-03-23 | 03-25 | Gibson Christopher | Director | S 公開市場賣出(10b5-1) | 40.0K | 3.25 | 130K | 907K | SEC |
| 2026-03-23 | 03-25 | Gibson Christopher | Director | C 轉換 | 40.0K | – | – | 947K | SEC |
| 2026-03-17 | 03-18 | Taylor Ben R | Chief Financial Officer | S 公開市場賣出(10b5-1) | 8.0K | 3.39 | 27K | 1.2M | SEC |
| 2026-03-16 | 03-18 | Taylor Ben R | Chief Financial Officer | F 繳稅扣股 | 7.1K | 3.42 | 24K | 1.2M | SEC |
| 2026-03-09 | 03-11 | Khan Najat | CEO and President | S 公開市場賣出(10b5-1) | 28.3K | 3.35 | 95K | 2.3M | SEC |
| 2026-03-09 | 03-11 | Gibson Christopher | Director | G 贈與 | 20.0K | – | – | 907K | SEC |
| 2026-03-09 | 03-11 | Gibson Christopher | Director | C 轉換 | 20.0K | – | – | 927K | SEC |
| 2026-03-03 | 03-04 | Borgeson Blake | Director | S 公開市場賣出(10b5-1) | 170K | 3.46 | 588K | 6.3M | SEC |
| 2026-02-19 | 02-19 | Gibson Christopher | Director | S 公開市場賣出(10b5-1) | 40.0K | 3.46 | 138K | 907K | SEC |
| 2026-02-19 | 02-19 | Gibson Christopher | Director | C 轉換 | 40.0K | – | – | 947K | SEC |
| 2026-02-18 | 02-19 | Taylor Ben R | Chief Financial Officer | S 公開市場賣出(10b5-1) | 13.4K | 3.08 | 41K | 1.2M | SEC |
| 2026-02-17 | 02-19 | Khan Najat | CEO and President | F 繳稅扣股 | 14.3K | 3.49 | 50K | 2.3M | SEC |
| 2026-02-17 | 02-19 | Hallett David | Chief Scientific Officer | F 繳稅扣股 | 11.9K | 3.49 | 42K | 1.1M | SEC |
| 2026-02-17 | 02-19 | Taylor Ben R | Chief Financial Officer | F 繳稅扣股 | 11.9K | 3.49 | 42K | 1.2M | SEC |
| 2026-02-17 | 02-19 | Gibson Christopher | Director | F 繳稅扣股 | 27.3K | 3.49 | 95K | 907K | SEC |
| 2026-02-06 | 02-10 | Taylor Ben R | Chief Financial Officer | A 獲配股票 | 24.3K | – | – | 1.2M | SEC |
| 2026-02-06 | 02-10 | Taylor Ben R | Chief Financial Officer | A 獲配股票 | 446K | – | – | 1.2M | SEC |
| 2026-02-06 | 02-10 | Hallett David | Chief Scientific Officer | F 繳稅扣股 | 11.4K | 3.98 | 45K | 1.1M | SEC |
| 2026-02-06 | 02-10 | Hallett David | Chief Scientific Officer | A 獲配股票 | 24.3K | – | – | 1.1M | SEC |
| 2026-02-06 | 02-10 | Taylor Ben R | Chief Financial Officer | F 繳稅扣股 | 11.4K | 3.98 | 45K | 1.2M | SEC |
| 2026-02-06 | 02-10 | Hallett David | Chief Scientific Officer | A 獲配股票 | 502K | – | – | 1.1M | SEC |
| 2026-02-06 | 02-10 | Khan Najat | CEO and President | A 獲配股票 | 30.3K | – | – | 2.3M | SEC |
| 2026-02-06 | 02-10 | Khan Najat | CEO and President | A 獲配股票 | 1.7M | – | – | 2.3M | SEC |
| 2026-02-06 | 02-10 | Khan Najat | CEO and President | F 繳稅扣股 | 10.4K | 3.98 | 41K | 2.3M | SEC |
| 2026-02-06 | 02-06 | Gibson Christopher | Director | F 繳稅扣股 | 10.4K | 3.56 | 37K | 934K | SEC |
| 2026-02-06 | 02-06 | Gibson Christopher | Director | A 獲配股票 | 30.3K | – | – | 944K | SEC |
| 2026-02-04 | 02-06 | Gibson Christopher | Director | C 轉換 | 40.0K | – | – | 954K | SEC |
| 2026-02-04 | 02-06 | Gibson Christopher | Director | S 公開市場賣出(10b5-1) | 40.0K | 4.12 | 165K | 914K | SEC |
| 2026-02-03 | 02-06 | Borgeson Blake | Director | S 公開市場賣出(10b5-1) | 220K | 4.20 | 924K | 6.4M | SEC |
| 2026-01-20 | 01-22 | Gibson Christopher | Director | C 轉換 | 40.0K | – | – | 954K | SEC |
| 2026-01-20 | 01-22 | Gibson Christopher | Director | S 公開市場賣出(10b5-1) | 40.0K | 4.47 | 179K | 914K | SEC |
| 2026-01-06 | 01-08 | Borgeson Blake | Director | S 公開市場賣出(10b5-1) | 220K | 4.36 | 959K | 6.6M | SEC |
| 2026-01-05 | 01-07 | Gibson Christopher | Director | G 贈與 | 20.0K | – | – | 914K | SEC |
| 2026-01-05 | 01-07 | Gibson Christopher | Director | S 公開市場賣出(10b5-1) | 40.0K | 4.25 | 170K | 934K | SEC |
| 2026-01-05 | 01-07 | Gibson Christopher | Director | C 轉換 | 60.0K | – | – | 974K | SEC |
| 2026-01-02 | 01-06 | Dar Zavain | Director | A 獲配股票 | 3.6K | – | – | 142K | SEC |
| 2026-01-02 | 01-06 | Li Dean Y | Director | A 獲配股票 | 2.4K | – | – | 1.2M | SEC |
| 2025-12-29 | 12-30 | Taylor Ben R | Chief Financial Officer | S 公開市場賣出(10b5-1) | 21.4K | 4.18 | 89K | 762K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 50.3M | 185M | 新進 | 新進 |
| 方舟(伍德) ARK Investment Management LLC | 41.3M | 152M | 新進 | 新進 |
| STATE STREET CORP | 34.7M | 127M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31.1M | 114M | 新進 | 新進 |
| BAILLIE GIFFORD & CO | 23.5M | 86.2M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 22.8M | 83.6M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 13.8M | 50.7M | 新進 | 新進 |
| SOFTBANK GROUP CORP. | 13.6M | 50.0M | 新進 | 新進 |
| MIC Capital Management UK LLP | 9.6M | 35.4M | 新進 | 新進 |
| UBS Group AG | 8.9M | 32.8M | 新進 | 新進 |
| 挪威主權基金 NORGES BANK | 6.8M | 25.1M | 新進 | 新進 |
| Data Collective IV GP, LLC | 5.9M | 21.8M | 新進 | 新進 |
| Amova Asset Management Americas, Inc. | 5.5M | 20.2M | 新進 | 新進 |
| Sumitomo Mitsui Trust Group, Inc. | 5.5M | 20.2M | 新進 | 新進 |
| NORTHERN TRUST CORP | 4.8M | 17.5M | 新進 | 新進 |
| MARSHALL WACE, LLP | 4.7M | 17.3M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4.1M | 15.2M | 新進 | 新進 |
| DCVC Opportunity Fund II GP, LLC | 4.0M | 14.5M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 3.9M | 14.4M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 3.5M | 12.7M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 3.4M | 12.3M | 新進 | 新進 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3.3M | 12.1M | 新進 | 新進 |
| FIRST TRUST ADVISORS LP | 3.0M | 11.2M | 新進 | 新進 |
| MORGAN STANLEY | 2.7M | 10.1M | 新進 | 新進 |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 2.6M | 9.6M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 343 +8 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 343 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 362M · 67.6% |
| 合計季末市值 | 1.3B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 179M |
|---|---|
| 與上期比 | +0.7% |
| 佔流通股數 | 33.46% |
| 日均成交量 | 16.9M |
| 回補天數 | 10.6 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 179M | +0.7% | 33.46% | 16.9M | 10.6 |
| 2026-08-14 | 178M | -1.6% | 33.24% | 13.3M | 13.4 |
| 2026-07-31 | 181M | +0.0% | 33.77% | 19.4M | 9.3 |
| 2026-07-15 | 181M | +4.9% | 33.77% | 26.9M | 6.7 |
| 2026-06-30 | 172M | -6.4% | 32.19% | 20.5M | 8.4 |
| 2026-06-15 | 184M | +12.0% | 34.37% | 22.0M | 8.4 |
| 2026-05-29 | 164M | -10.9% | 30.70% | 20.5M | 8.0 |
| 2026-05-15 | 184M | +7.7% | 34.45% | 13.9M | 13.3 |
| 2026-04-30 | 171M | -1.8% | 32.00% | 11.6M | 14.8 |
| 2026-04-15 | 174M | +0.3% | 32.58% | 10.2M | 17.1 |
| 2026-03-31 | 174M | -0.1% | 32.49% | 14.1M | 12.3 |
| 2026-03-13 | 174M | +3.3% | 32.53% | 13.7M | 12.7 |
| 2026-02-27 | 169M | -2.7% | 31.48% | 19.0M | 8.9 |
| 2026-02-13 | 173M | +4.6% | 32.35% | 22.7M | 7.6 |
| 2026-01-30 | 166M | +1.3% | 30.92% | 20.8M | 8.0 |
| 2026-01-15 | 163M | -1.4% | 30.52% | 20.0M | 8.2 |
| 2025-12-31 | 166M | +7.8% | 30.96% | 27.0M | 6.1 |
| 2025-12-15 | 154M | +1.2% | 28.72% | 18.7M | 8.2 |
| 2025-11-28 | 152M | +4.3% | 28.37% | 23.4M | 6.5 |
| 2025-11-14 | 146M | +13.3% | 27.21% | 37.5M | 3.9 |
| 2025-10-31 | 129M | +1.8% | 24.02% | 64.7M | 2.0 |
| 2025-10-15 | 126M | -5.3% | 23.60% | 69.4M | 1.8 |
| 2025-09-30 | 133M | +1.0% | 24.92% | 35.9M | 3.7 |
| 2025-09-15 | 132M | +6.4% | 24.67% | 16.7M | 7.9 |
| 2025-08-29 | 124M | +1.5% | 23.18% | 16.3M | 7.6 |
| 2025-08-15 | 122M | +4.0% | 22.83% | 18.6M | 6.6 |